Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Non profit bodies get together to find cures for neglected diseases

This article was originally published in Scrip

Executive Summary

Two not-for-profit organisations have signed a royalty-free licence agreement that aims to speed up the development of new therapies for neglected diseases. The TB Alliance will give the Drugs for Neglected Disease initiative (DNDi) the rights to its library of TB drugs, the nitroimidazole class, to develop as potential treatments against a number of neglected tropical diseases, including visceral leishmaniasis, sleeping sickness and Chagas disease.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC009456

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel